- €41.72m
- €50.36m
- €12.70m
- 46
- 23
- 90
- 51
Annual income statement for Osmozis SA, fiscal year end - August 31st, EUR millions except per share, conversion factor applied.
2019 August 31st | 2020 August 31st | 2021 August 31st | 2022 August 31st | 2023 August 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | FAS | FAS | FAS | FAS | FAS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 8.47 | 8.01 | 9.59 | 11.6 | 12.7 |
| Cost of Revenue | |||||
| Gross Profit | 9.55 | 8.97 | 11.6 | 13.8 | 14.8 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 8.04 | 9.62 | 8.73 | 10.2 | 11.2 |
| Operating Profit | 0.427 | -1.61 | 0.86 | 1.37 | 1.53 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 0.41 | -2.46 | 0.754 | 1.22 | 0.804 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 0.265 | -1.97 | 0.99 | 1.01 | 0.702 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 0.265 | -1.97 | 0.99 | 1.01 | 0.702 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 0.265 | -1.97 | 0.99 | 1.01 | 0.702 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.123 | -0.878 | 0.5 | 0.494 | 0.315 |
| Dividends per Share |